GFI #256

34 members of Congress ask FDA to cite statutory authority for GFI #256

0 comment(s)
Ted Yoho (R-FL), Mark Pocan (D-WI), and Donald Norcross (D-NJ), members of the U.S. House of Representatives, are the lead sponsors of a letter sent to Food and Drug Administration Commissioner, Stephen Hahn, M.D., expressing their concerns about the FDA’s draft Guidance for Industry #256 - Compounding Animal Drugs from Bulk Drug Substances.
 

Report Language for FDA Appropriations Bill Includes Directions About Compounding

0 comment(s)
FDA Logo

The report language for the bill that funds the Food and Drug Administration (FDA) has been released by the U.S. House of Representatives Committee on Appropriations. While this language does not have the force of law, it instructs federal agencies on actions to take as part of accepting new funding from Congress.

Here are excerpts that relate to compounding pharmacy: